Synergistic innate immune activation and anti-tumor immunity through combined STING and TLR4 stimulation
This study shows that combining STING and TLR4 agonists enhances IFN-{beta} production and anti-tumor immunity through synergistic activation of NF-{kappa}B and IRF3 pathways.
bioRxiv · Apr 8, 2024 · PreprintImmunology